Financials & SEC Filings - Stoke Therapeutics

Filing date	Description	Form	View
June 18, 2019	EFFECT	EFFECT	9999999995-19-001367.pdf 9999999995-19-001367.rtf View HTML
July 20, 2020	EFFECT	EFFECT	9999999995-20-001866.xls View HTML
May 31, 2022	EFFECT	EFFECT	9999999995-22-001648.pdf 9999999995-22-001648.rtf 9999999995-22-001648.xls View HTML
April 30, 2019	mendment to a previously filed DRS	DRS/A	0000950123-19-003688.pdf 0000950123-19-003688.rtf 0000950123-19-003688.xls View HTML
March 26, 2019	Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy	DRS	0000950123-19-002845.pdf 0000950123-19-002845.rtf 0000950123-19-002845.xls View HTML
April 21, 2020	Additional proxy soliciting materials - definitive	DEFA14A	0001193125-20-113561.pdf 0001193125-20-113561.rtf 0001193125-20-113561.xls View HTML
April 26, 2021	Additional proxy soliciting materials - definitive	DEFA14A	0001193125-21-131456.pdf 0001193125-21-131456.rtf 0001193125-21-131456.xls View HTML
April 26, 2022	Additional proxy soliciting materials - definitive	DEFA14A	0001193125-22-120215.pdf 0001193125-22-120215.rtf 0001193125-22-120215.xls View HTML
April 27, 2023	Additional proxy soliciting materials - definitive	DEFA14A	0001193125-23-122102.pdf 0001193125-23-122102.rtf View HTML
May 24, 2023	Additional proxy soliciting materials - definitive	DEFA14A	0001193125-23-153061.pdf 0001193125-23-153061.rtf View HTML

Data provided by Kaleidoscope.